Factors Associated with Delays in Initiating Biologic Therapy in Patients with Inflammatory Bowel Disease.
Alexander AbadirAngela TroiaHyder SaidSpurthi TaruguBenjamin C BillingsleyNathan SairamScott B MinchenbergAnna H OwingsAdam M ParkerBrandon BrousseAlexander CarlyleBobby R OwensPegah Hosseini-CarrollMichelle Galeas-PenaJoseph FrascaSarah C GloverKonstantinos PapamichaelAdam S CheifetzPublished in: Digestive diseases and sciences (2024)
There may be a significant delay in biologic treatment initiation in patients with IBD. The most important variables associated with this delay included self-identification as Black, longer distance from site, and lack of initial insurance coverage approval.